Human Immunodeficiency Virus Preexposure Prophylaxis: Meeting the Needs of Transgender Populations

被引：2
|
作者：
Krakower, Douglas S. [1 ]
机构：
[1] Beth Israel Deaconess Med Ctr, Div Infect Dis, 110 Francis St, Boston, MA 02215 USA
来源：
CLINICAL INFECTIOUS DISEASES | 2021年 / 73卷 / 07期
关键词：
HIV; HIV prevention; preexposure prophylaxis; transgender populations; clinical pharmacology;
D O I：
10.1093/cid/ciaa1158
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：E2124 / E2126
页数：3
相关论文
共 50 条
  • [41] Meeting the Needs of the Transgender Nursing Student
    Levesque, Pamela
    NURSE EDUCATOR, 2015, 40 (05) : 244 - 248
  • [42] Pharmacotherapy considerations in transgender individuals living with human immunodeficiency virus
    Badowski, Melissa E.
    Britt, Nicholas
    Huesgen, Emily C.
    Lewis, Michelle M.
    Miller, Misty M.
    Nowak, Kathleen
    Sherman, Elizabeth
    Smith, Renata O.
    PHARMACOTHERAPY, 2021, 41 (03): : 299 - 314
  • [43] The Cost-effectiveness of Human Immunodeficiency Virus (HIV) Preexposure Prophylaxis and HIV Testing Strategies in High-risk Groups in India
    Kazemian, Pooyan
    Costantini, Sydney
    Kumarasamy, Nagalingeswaran
    Paltiel, A. David
    Mayer, Kenneth H.
    Chandhiok, Nomita
    Walensky, Rochelle P.
    Freedberg, Kenneth A.
    CLINICAL INFECTIOUS DISEASES, 2020, 70 (04) : 633 - 642
  • [44] Incidence of Gonorrhea and Chlamydia Following Human Immunodeficiency Virus Preexposure Prophylaxis Among Men Who Have Sex With Men: A Modeling Study
    Jenness, Samuel M.
    Weiss, Kevin M.
    Goodreau, Steven M.
    Gift, Thomas
    Chesson, Harrell
    Hoover, Karen W.
    Smith, Dawn K.
    Liu, Albert Y.
    Sullivan, Patrick S.
    Rosenberg, Eli S.
    CLINICAL INFECTIOUS DISEASES, 2017, 65 (05) : 712 - 718
  • [45] Vital Signs: Status of Human Immunodeficiency Virus Testing, Viral Suppression, and HIV Preexposure Prophylaxis - United States, 2013-2018
    Harris, Norma S.
    Johnson, Anna Satcher
    Huang, Ya-Lin A.
    Kern, Dayle
    Fulton, Paul
    Smith, Dawn K.
    Valleroy, Linda A.
    Hall, H. Irene
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2019, 68 (48): : 1117 - 1123
  • [46] Am I Positive? Improving Human Immunodeficiency Virus Testing in the Era of Preexposure Prophylaxis and Immediate Antiretroviral Therapy Using Machine Learning
    Zucker, Jason
    Carnevale, Caroline
    Gordon, Peter
    Sobieszczyk, Magdalena E.
    Rai, Alex J.
    OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (07):
  • [47] Impact of Providing Preexposure Prophylaxis for Human Immunodeficiency Virus at Clinics for Sexually Transmitted Infections in Baltimore City: An Agent-based Model
    Kasaie, Parastu
    Berry, Stephen A.
    Shah, Maunank S.
    Rosenberg, Eli S.
    Hoover, Karen W.
    Gift, Thomas L.
    Chesson, Harrell
    Pennington, Jeff
    German, Danielle
    Flynn, Colin P.
    Beyrer, Chris
    Dowdy, David W.
    SEXUALLY TRANSMITTED DISEASES, 2018, 45 (12) : 791 - 797
  • [48] Prophylaxis for opportunistic infections in patients with human immunodeficiency virus
    Katlama, C
    Jouan, M
    MEDECINE ET MALADIES INFECTIEUSES, 1996, 26 (8-9): : 742 - 751
  • [49] Randomized Controlled Trial of Daily Text Messages to Support Adherence to Preexposure Prophylaxis in Individuals at Risk for Human Immunodeficiency Virus: The TAPIR Study
    Moore, David J.
    Jain, Sonia
    Dube, Michael P.
    Daar, Eric S.
    Sun, Xiaoying
    Young, Jason
    Corado, Katya
    Ellorin, Eric
    Milam, Joel
    Collins, Deborah
    Blumenthal, Jill
    Best, Brookie M.
    Anderson, Peter
    Haubrich, Richard
    Morris, Sheldon R.
    CLINICAL INFECTIOUS DISEASES, 2018, 66 (10) : 1566 - 1572
  • [50] Human Immunodeficiency Virus Preexposure Prophylaxis for Adolescent Men How Do We Ensure Health Equity for At-Risk Young Men?
    Arrington-Sanders, Renata
    JAMA PEDIATRICS, 2017, 171 (11) : 1041 - 1042
12345